Skip to content
This website uses cookies to help us understand the way visitors use our website. We can't identify you with them and we don't share the data with anyone else. If you click Reject we will set a single cookie to remember your preference. Find out more in our privacy policy.

Navigation breadcrumbs

  1. Home
  2. Who we are
  3. How we are funded
  4. Our work with industry

Our work with industry


While most of our income comes from public sector and not-for-profit organisations, for some programmes of work, where appropriate, we develop joint or collaborative working agreements with commercial organisations.

These agreements can provide additional funding to enable our work to benefit more patients, while ensuring the health and care system benefits from new innovations in health and care. They can also bring supplementary capacity and capability to the NHS and can valuable insights to non-NHS stakeholders.

As part of the Health Innovation Network, we adopt the following principles in our work with industry:

  • Patients’ needs first
  • Improving value from public money
  • Alignment with local and national priorities
  • A balanced, whole systems approach to healthcare
  • Openness and transparency

Our goal is to enable collaborative relationships within long-term projects based upon mutual recognition and regard.

In line with the Association of British HealthTech Industries (ABHI) code of ethical business conduct and Association of the British Pharmaceutical Industry (ABPI) code of practice, from April 2022 onwards, all Health Innovation Networks, including UCLPartners, have decided to disclose details of joint working agreements with industry, as well as any donations by non-profit making or charitable organisations (together known as ‘transfers of value’) on an annual basis as a minimum.

UCLPartners’ projects with industry 2022/23